Infection Control & Hospital Epidemiology
professional societies and that they modify and/or add AMS program strategies as appropriate. The AMS team can test, evaluate, and modify interventions using a plan-do-study-act cycle.31 Regular meetings should be scheduled with the AMS team and clinical staff most affected by the AMS program to make necessary changes to the program.11,31 Ongoing training and departmental feedback sessions are also important, where the purpose, evidence-based importance, and positive outcomes of the AMS program can be emphasized.11,31 Finally, education about the AMS program should be provided as part of orientation for new staff, with regular updates to keep all staff informed about any changes to the antibiogram and the AMS program.
Supplementary material. To view supplementary material for this article, please visit
https://doi.org/10.1017/ice.2018.188
Acknowledgments. The authors acknowledge the healthcare team from Weber Shandwick Hong Kong for their support in preparing the manuscript, which was funded by an unrestricted educational grant from Pfizer, Inc. The sponsor had no role in the preparation, review, or approval of the manuscript, or in the decision to submit for publication. The authors alone are responsible for the content and the recommendations, and the decision to submit for publication.
Financial support. The initial meeting held between the authors to discuss and prepare this manuscript was funded by an unrestricted educational grant from Pfizer, Inc.
Conflicts of interest. S.K. has received grant support from Pfizer, Inc. M.F. T. has been a committee member of the Pfizer Philippines Advisory Board. L. R.P received consultation fees from Pfizer, Inc, during the conduct of the study and has worked with several diagnostic companies (Cepheid, Becton-Dick- inson, and Roche) as well as the National Institutes of Health (US) on the development of new infectious disease testing that in the future could be beneficial to antimicrobial stewardship. All other authors have nothing to declare.
References
1. O’Neill J. Tackling drug-resistant infections globally: final report and recommendations. Review on Antimicrobial Resistance website. https://
amr-review.org/sites/default/files/160518_Final paper_with cover.pdf. Pub- lished May 2016. Accessed November 15, 2017.
2. Antimicrobial resistance in the Western Pacific Region: a review of surveillance and health systems response, 2015. World Health Organization website.
http://apps.who.int/medicinedocs/documents/s22116en/s22116en. pdf. Published 2015. Accessed November 15, 2017.
3. Kang C-I, Song J-H. Antimicrobial resistance in Asia: current epidemiology and clinical implications. Infect Chemother 2013;45:22–31.
4. Lai C-C, Lee K, Xiao Y, et al. High burden of antimicrobial drug resistance in Asia. J Glob Antimicrob Resist. 2014;2:141–147.
5. Action agenda for antimicrobial resistance in the Western Pacific Region, 2015. World Health Organization website.
http://www.wpro.who.int/entity/ drug_resistance/documents/action_agenda.pdf. Published 2015. Accessed November 15, 2017.
6. Hsu L-Y, Apisarnthanarak A, Khan E, Suwantarat N, Ghafur A, Tambyah PA. Carbapenem-resistant Acinetobacter baumannii and Enterobacteriaceae in South and Southeast Asia. Clin Microbiol Rev 2017;30:1–22.
7. Suwantarat N, Carroll KC. Epidemiology and molecular characterization of multidrug-resistant gram-negative bacteria in Southeast Asia. Antimicrob Resist Infect Control 2016;5:15.
8. Barlam TF, Cosgrove SE, Abbo LM, et al. Implementing an antibiotic stewardship program: guidelines by the Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America. Clin Infect Dis 2016;62:e51–e77.
1243
9. Howard P, Pulcini C, Levy Hara G, et al. An international cross-sectional survey of antimicrobial stewardship programmes in hospitals. J Antimicrob Chemother 2015;70:1245–1255.
10. Sing DYF, Boo YL, Mukhlis R, Chin PW, Hoo FK. Antimicrobial stewardship program in a Malaysian district hospital: first year experience. Pakistan J Med Sci 2016;32:999–1004.
11. Teng CB, Lee W, Yeo CL, et al. Guidelines for antimicrobial stewardship training and practice. Ann Acad Med Singapore 2012;41:29–34.
12. Tiong JJL, Loo JSE,Mai C-W. Global antimicrobial stewardship: a closer look at the formidable implementation challenges. Front Microbiol 2016;7:1860.
13. Wertheim HFL, Chandna A, Vu PD, et al. Providing impetus, tools, and guidance to strengthen national capacity for antimicrobial stewardship in Viet Nam. PLoS Med 2013;10:e1001429.
14. Antimicrobial stewardship: systems and processes for effective antimi- crobial medicine use, August 2015. National Institute for Health and Care Excellence (NICE) website.
https://www.nice.org.uk/guidance/ng15. Pub- lished 2015. Accessed November 15, 2017.
15. Pollack LA, Srinivasan A. Core elements of hospital antibiotic stewardship programs from the Centers for Disease Control and Prevention. Clin Infect Dis 2014;59 Suppl 3:S97–S100.
16. Baur D, Gladstone BP, Burkert F, et al. Effect of antibiotic stewardship on the incidence of infection and colonisation with antibiotic-resistant bacteria and Clostridium difficile infection: a systematic review and meta- analysis. Lancet Infect Dis 2017;17:990–1001.
17. Honda H, Ohmagari N, Tokuda Y, Mattar C, Warren DK. Antimicrobial stewardship in inpatient settings in the Asia Pacific Region: a systematic review and meta-analysis. Clin Infect Dis 2017;64:S119–S126.
18. Schuts EC, Hulscher MEJL, Mouton JW, et al. Current evidence on hospital antimicrobial stewardship objectives: a systematic review and meta-analysis. Lancet Infect Dis 2016;16:847–856.
19. Levy Hara G. Antimicrobial stewardship in hospitals: Does it work and can we do it? J Glob Antimicrob Resist 2014;2:1–6.
20. Nguyen K Van, Thi Do NT, Chandna A, et al. Antibiotic use and resistance in emerging economies: a situation analysis for Viet Nam. BMC Public Health 2013;13:1158.
21. Wang L, Zhang X, Liang X, Bloom G. Addressing antimicrobial resistance in China: policy implementation in a complex context. Global Health 2016;12:30.
22. Hadi U, Keuter M, van Asten H, van den Broek P, Study Group “Antimicrobial resistance in Indonesia: Prevalence and Prevention” (AMRIN). Optimizing antibiotic usage in adults admitted with fever by a multifaceted intervention in an Indonesian governmental hospital. Trop Med Int Health 2008;13:888–899.
23. Om C, Daily F, Vlieghe E, McLaughlin JC, McLaws M-L. “If it’s a broad spectrum, it can shoot better”: inappropriate antibiotic prescribing in Cambodia. Antimicrob Resist Infect Control 2016;5:58.
24. Dellit TH, Owens RC, McGowan JE, et al. Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America guidelines for developing an institutional program to enhance anti- microbial stewardship. Clin Infect Dis 2007;44:159–77.
25. Doron S, Davidson LE. Antimicrobial stewardship. Mayo Clin Proc 2011;86:1113–1123.
26. Akpan MR, Ahmad R, Shebl NA, Ashiru-Oredope D. A review of quality measures for assessing the impact of antimicrobial stewardship programs in hospitals. Antibiotics 2016;5.
27. Davey P, Marwick CA, Scott CL, et al. Interventions to improve antibiotic prescribing practices for hospital inpatients. Cochrane Database Syst Rev 2017;2:CD003543.
28. Karanika S, Paudel S, Grigoras C, Kalbasi A, Mylonakis E. Systematic review and meta-analysis of clinical and economic outcomes from the implementation of hospital-based antimicrobial stewardship programs. Antimicrob Agents Chemother 2016;60:4840–4852.
29. Kim J, Craft DW, Katzman M. Building an Antimicrobial stewardship program: cooperative roles for pharmacists, infectious diseases specialists, and clinical microbiologists. Lab Med 2015;46:e65–e71.
30. Waters CD. Pharmacist-driven antimicrobial stewardship program in an institution without infectious diseases physician support. Am J Health Syst Pharm 2015;72:466–468.
Page 1 |
Page 2 |
Page 3 |
Page 4 |
Page 5 |
Page 6 |
Page 7 |
Page 8 |
Page 9 |
Page 10 |
Page 11 |
Page 12 |
Page 13 |
Page 14 |
Page 15 |
Page 16 |
Page 17 |
Page 18 |
Page 19 |
Page 20 |
Page 21 |
Page 22 |
Page 23 |
Page 24 |
Page 25 |
Page 26 |
Page 27 |
Page 28 |
Page 29 |
Page 30 |
Page 31 |
Page 32 |
Page 33 |
Page 34 |
Page 35 |
Page 36 |
Page 37 |
Page 38 |
Page 39 |
Page 40 |
Page 41 |
Page 42 |
Page 43 |
Page 44 |
Page 45 |
Page 46 |
Page 47 |
Page 48 |
Page 49 |
Page 50 |
Page 51 |
Page 52 |
Page 53 |
Page 54 |
Page 55 |
Page 56 |
Page 57 |
Page 58 |
Page 59 |
Page 60 |
Page 61 |
Page 62 |
Page 63 |
Page 64 |
Page 65 |
Page 66 |
Page 67 |
Page 68 |
Page 69 |
Page 70 |
Page 71 |
Page 72 |
Page 73 |
Page 74 |
Page 75 |
Page 76 |
Page 77 |
Page 78 |
Page 79 |
Page 80 |
Page 81 |
Page 82 |
Page 83 |
Page 84 |
Page 85 |
Page 86 |
Page 87 |
Page 88 |
Page 89 |
Page 90 |
Page 91 |
Page 92 |
Page 93 |
Page 94 |
Page 95 |
Page 96 |
Page 97 |
Page 98 |
Page 99 |
Page 100 |
Page 101 |
Page 102 |
Page 103 |
Page 104 |
Page 105 |
Page 106 |
Page 107 |
Page 108 |
Page 109 |
Page 110 |
Page 111 |
Page 112 |
Page 113 |
Page 114 |
Page 115 |
Page 116 |
Page 117 |
Page 118 |
Page 119 |
Page 120 |
Page 121 |
Page 122 |
Page 123 |
Page 124 |
Page 125 |
Page 126 |
Page 127 |
Page 128 |
Page 129 |
Page 130 |
Page 131 |
Page 132 |
Page 133 |
Page 134 |
Page 135 |
Page 136 |
Page 137 |
Page 138 |
Page 139 |
Page 140 |
Page 141 |
Page 142 |
Page 143 |
Page 144
